IndraLab

Statements

RIPK2-S176A inhibits MYSM1. 1 / 1

| 1

reach

"The Ripk2 S176D mutation accelerated OA pathogenesis, while Ripk2 silencing or Ripk2 S176A mutation deactivated NF-kappaB and MAPK pathways, counteracting the role of MYSM1."

39746943

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

RIPK2-S176A inhibits MYSM1. 1 / 1

INDRA sources:

Databases

Reading